Literature DB >> 7085596

Lysophosphatidylcholine metabolism in the rabbit heart. Characterization of metabolic pathways and partial purification of myocardial lysophospholipase-transacylase.

R W Gross, B E Sobel.   

Abstract

Metabolism of lysophosphatidylcholine (LPC), recently implicated in arrhythmogenesis, was characterized in rabbit ventricular homogenates. Activities of four enzymatic pathways were distinguishable after subcellular fractionation and DEAE-Sephacel chromatography including microsomal lysophospholipase, microsomal acyl coenzyme A/LPC acyltransferase, cytosolic lysophospholipase, and cytosolic lysophospholipase-transacylase. Microsomal lysophospholipase activity was attenuated 81% by acidosis comparable to that in ischemic myocardium (pH 6.5) and was inhibited by substrate. LPC acyltransferase was identified in the microsomal fraction based on CoA-dependent phosphatidyl choline synthesis, the positional specificity of acylation of LPC, and identical reaction velocities with both of its labeled co-substrates. LPC acyltransferase had a Vmax of 5.1 nmol/mg/min, a broad pH optimum centered at pH 7, and an apparent Km for LPC and palmitoyl-CoA of 14 microM and 7 microM. Cytosolic lysophospholipase was separated from lysophospholipase-transacylase by DEAE-Sephacel chromatography and distinguished from microsomal lysophospholipase by its broad pH activity curve, Michaelis-Menten kinetics (Vmax = 9.5 nmol/mg/min, Km = 7.5 microM), and lack of substrate inhibition. Lysophospholipase-transacylase was identified in the cytosolic fraction by CoA-independent phosphatidyl choline synthesis and purified 4885-fold from homogenate by ammonium sulfate precipitation, DEAE-Sephacel, hydroxylapatite, gel filtration, and polylysine chromatography. The partially purified enzyme had a transacylase/lysophospholipase activity ratio of 0.6, and transacylation of LPC was prominent at submicellar concentrations of substrate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7085596

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Calcium-independent phospholipase A2 in isolated rabbit ventricular myocytes.

Authors:  J McHowat; M H Creer
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

2.  Mechanism of lysophosphatidylcholine accumulation in the ischemic canine heart.

Authors:  T Mock; R Y Man
Journal:  Lipids       Date:  1990-07       Impact factor: 1.880

3.  The leakage of fatty acid binding protein from cultured myocardial cells during hypoxia.

Authors:  H Takahashi; H Kawaguchi; K Iizuka; H Yasuda
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

Review 4.  Subcellular distribution, molecular dynamics and catabolism of plasmalogens in myocardium.

Authors:  L A Scherrer; R W Gross
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

5.  The acylation of lysophosphoradylglycerocholines in guinea-pig heart mitochondria.

Authors:  G Arthur; L L Page; C L Zaborniak; P C Choy
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

6.  Protease activation of calcium-independent phospholipase A2 leads to neutrophil recruitment to coronary artery endothelial cells.

Authors:  Maureen C White; Jane McHowat
Journal:  Thromb Res       Date:  2006-12-22       Impact factor: 3.944

7.  Regulation by vitamin E of phosphatidylcholine metabolism in rat heart.

Authors:  Y Z Cao; K O; P C Choy; A C Chan
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

8.  Butyric acid-induced differentiation of HL-60 cells increases the expression of a single lysophospholipase.

Authors:  D Garsetti; F Holtsberg; M R Steiner; R W Egan; M A Clark
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

9.  Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion.

Authors:  A Sen; J C Miller; R Reynolds; J T Willerson; L M Buja; K R Chien
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

10.  Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation.

Authors:  P B Corr; M H Creer; K A Yamada; J E Saffitz; B E Sobel
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.